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Summary
Objective: Since mitochondrial DNA (mtDNA) mutations have been established to associate with the aging process and some degenerative
diseases, we investigated the correlation between idiopathic osteoarthritis (OA) and the 4977-bp mtDNA deletion.
Design: Cartilage were collected from six sites in knee joints removed from 18 aged patients with idiopathic OA, 10 aged non-OA cadavers, 3
young cadavers (YC), and lateral femoral condyle of 9 young patients. Histopathologic changes were examined and the common 4977-bp
mtDNA deletions were analyzed in young and elderly cartilages obtained from different sites in the knee joint. The association of the 4977-bp
deletion of mtDNA with idiopathic OA and aging was evaluated.
Results: The 4977-bp mtDNA deletion was detected in 17 of the 18 OA patients, 9 of the 10 aged non-OA cadavers, and 1 of the 3 YC. None
of the nine specimens collected from the lateral femoral condyle of young patients had a detectable deletion of mtDNA. The 4977-bp mtDNA
deletion was not signiﬁcantly correlated with the severity of OA graded by the Mankin score. The frequencies of occurrence of the 4977-bp
mtDNA deletion were signiﬁcantly different between the OA group and the aged non-OA control group (PZ 0.004) and between the aged non-
OA group and the young control group (PZ 0.002).
Conclusions: The results suggest that accumulation of the 4977-bp deletion of mtDNA in knee cartilage increases with age and may play
a role in the development of idiopathic OA in the knee joint.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA), also known as degenerative joint
disease, is the most common of more than 100 different
types of arthritis. OA is characterized by the breakdown of
a joint’s cartilage, which causes adjacent bones to rub
directly against each other. This results in varying degrees
of pain severity and restricted joint mobility. OA affects
millions of people around the world; an estimated 20.7
million people suffer from OA in the United States alone.
Before 45 years of age, OA occurs more frequently in men;
however, after 55 years of age, it occurs more frequently in
women.
Primary or idiopathic OA is mainly related to aging.
Secondary OA is typically triggered by another malady.
Several factors may contribute to OA, including age, sex,
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obesity, congenital or developmental defects, prior inﬂam-
matory joint disease, and metabolic or endocrine disor-
ders36. However, the predisposing factors that lead to the
development of idiopathic OA remain unclear30.
Although idiopathic OA occurs more frequently in elderly
people21e23, there are signiﬁcant biomechanical and
biochemical differences between normal elderly cartilage
and osteoarthritic elderly cartilage2,15,18,34,46. In normal
elderly cartilage, reduced compliance may be associated
with increases in surface contact area10, cell density40,47,
water content, proteoglycan monomer length, glycosami-
noglycan and hyaluronic acid levels, chondroitin sulfate to
keratan sulfate ratio15,18,46, and chondroitin 6-sulfate to
chondroitin 4-sulfate ratio10,16,35. In osteoarthritic cartilage,
reduced compliance is associated with decreases in water
content2,34 and chondroitin sulfate to keratan sulfate
ratio33 and increases in proteoglycan32 and hyaluronic
acid43 levels. These inconsistent ﬁndings suggest that
factors other than those associated with age may be
responsible for idiopathic OA.
Free-radical-elicited oxidative damage to macromole-
cules has been established as a contributory factor in the04
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radical attack13. Accumulation of lipid peroxides and
mitochondrial DNA (mtDNA) mutations and increase in
the manganese superoxide dismutase (MneSOD) level are
early molecular events associated with human aging41,42.
Mutations in mtDNA have also been associated with aging
and degenerative diseases in the central nervous sys-
tem5,7,17,29,49, heart4,7,14,28 and skeletal muscles4,27,29.
We examined histopathologic changes and analyzed
mtDNA mutations, in particular the common 4977-bp
deletion, in young and elderly cartilages obtained from
different sites in the knee joint. We also evaluated the
association of the 4977-bp deletion of mtDNA with
idiopathic OA and aging.
Materials and methods
SUBJECTS AND COLLECTION OF SPECIMENS
Cartilage specimens were collected from 18 patients who
received total knee replacement for idiopathic OA in the
Department of orthopedics Taipei Veterans General Hos-
pital, Taiwan. The patients (9 males and 9 females) ranged
in age from 54 years to 79 years. Cartilage specimens were
obtained from six sites on the removed knee joint surfaces,
including the outer edge of the lateral tibial condyle with
meniscal coverage (Site 1), the central part of the lateral
tibial condyle without meniscal coverage (Site 2), the
medial edge of the medial tibial condyle with meniscal
coverage (Site 3), the central part of the medial tibial
condyle without meniscal coverage (Site 4), the inferior-
central part of the lateral femoral condyle (Site 5), and the
inferior-central part of the medial femoral condyle (Site 6).
Cartilage specimens were also collected from these six
sites in knee joints from 13 cadavers (17e85 years of age)
who had no known history of knee joint diseases and no
extensive irregularity of the surface with softening and
obvious thinning of the cartilage. The cadaver specimens
were excised from the smooth, bluish-translucent or
opaque and ﬁrm part of the cartilage when mild irregularity
or softening of the cartilage surface was evident. All
specimens were excised with a scalpel. The entire
thickness of the cartilage was saved but bone was carefully
removed. In addition, cartilage specimens were collected
from the medial edge of the lateral femoral condyle in nine
patients (7 males and 1 female aged 17e46 years) during
arthroscopic surgery for anterior cruciate ligament recon-
struction.
All specimens collected from idiopathic OA patients were
cut into two pieces and stored at 70(C immediately after
surgical resection; one piece was examined histopatholog-
ically and the other was analyzed for mtDNA deletions. The
specimens collected from the cadavers and from the nine
patients who had arthroscopic knee surgery were stored at
70(C after resection and were used only for mtDNA
deletion analysis; these specimens served as the controls.
This control group was subdivided into two groups. The
young-aged (YC) group included three cadavers (27-year-
old male, 23-year-old male, and 17-year-old female) and the
nine young patients who had anterior cruciate ligament
reconstruction (7 males and 1 female; 17e46 years of age,
average age 27.4 years). The aged (AC) group included 10
cadavers (7 males and 3 females; 53e85 years of age,
average age 65.9 years).
This study was conducted according to a protocol
approved by the Medical Ethics Committee for Conducting
Human Research at Taipei Veterans General Hospital.HISTOPATHOLOGIC EXAMINATION
For light microscopy, specimens were cut into 5-mm
blocks, ﬁxed in 3.8% formaldehyde solution for 72 h,
decalciﬁed in 10% ethylenediamine tetraacetic acid for 10
days, and embedded in parafﬁn. Sagittal sections (4 mm
thickness) were cut perpendicular to the surface of the
articular cartilage. Sections were stained with either
hematoxylin and eosin (HE) or Safranin-O stain and then
examined and graded according to the Mankin score for
arthritis32. Drs S.H. Hung and W.Y.K. Chen, who are well
trained in cartilage histopathology, simultaneously exam-
ined the specimens, and the ﬁnal scores were recorded
according to the grading of these two examiners.
DNA EXTRACTION AND POLYMERASE CHAIN REACTION (PCR)
Total cellular DNA was extracted from the specimens by
proteinase K/SDS lysis and phenol/chloroform extrac-
tion37,48. After ethanol precipitation, the DNA was dissolved
in deionized sterile water and stored at 30(C.
Deletions of mtDNA were detected by a previously
described PCR method24. Primers L8150 (nucleotide
positions 8150e8169) (5#-CCGGGGGTATACTACGGT
CA-3#) and H13650 (np 13650e13631) (5#-GGGGAAGC
GAGGTTGACCTG-3#) were used to amplify a 524-bp PCR
product from mtDNA with 4977-bp deletion. The other large-
scale deletions in the hot-spot regions of mtDNA were
detected by PCR with the primers L7901 (np 7901e7920)
(5#-TGAACCTACGAGTACACCGA-3#) and H16540 (np
16540e16521) (5#-GTGGGCTATTTAGGCTTTAT-3#). The
reactions were carried out in a PerkineElmer/Cetus DNA
thermal cycler (PerkineElmer Cetus, Norwalk, CT) for 35
cycles in a 50 ml reaction mixture containing 200 ng DNA,
200 mM of each dNTP, 40 pmol of each primer, 1.0 U of
Taq DNA polymerase, 50 mM KCl, 1.5 mM MgCl2, 10 mM
TriseHCl (pH 9.0), 0.1% Triton X-100, and 0.01% (w/v)
gelatin. The PCR cycles consisted of a 15-s denaturation at
94(C, a 15-s annealing at 58(C, and a 40-s primer
extension at 72(C. The PCR products were separated by
electrophoresis on a 1.5% agarose gel at 100 V for 40 min.
The DNA bands were detected under UV trans-illumination
after 0.01% ethidium bromide staining.
DETERMINATION OF THE PROPORTION OF mtDNA
WITH 4977-BP DELETION
The proportion of mtDNA with the 4977-bp deletion was
determined by a semi-quantitative PCR method24. Before
PCR ampliﬁcation, each DNA sample was serially diluted
twofold with distilled water in the range between 20 and 222.
The primers L3304 (np 3304e3323) (5#-AACATACC
CATGGCCAACCT-3#) and H3836 (np 3836e3817) (5#-
GGCAGGAGTAATCAGAGGTG-3#) were used to amplify
a 533-bp DNA fragment from the total mtDNA. The primers
L8150 (np 8150e8169) and H13650 (np 13650e13631)
were used to amplify a 524-bp PCR product from the 4977-
bp-deleted mtDNA.
The proportion of mtDNA with the 4977-bp deletion was
calculated as the ratio of the highest dilution at which the
524-bp PCR product could be ampliﬁed from the 4977-bp-
deleted mtDNA to the highest dilution at which the 533-bp
PCR product could be ampliﬁed from the total mtDNA in the
sample.
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Nonparametric ManneWhitney U test was used to
evaluate the correlations between the proportion of the
4977-bp mtDNA deletion and the Mankin score in each
sampling area. KruskaleWallis H test was used to analyze
the frequency of the 4977-bp mtDNA deletion in each
sampling area of the knee cartilage. Chi-square test was
used to examine the difference in the frequency of
occurrence of the 4977-bp mtDNA deletion between OA
and control groups. The difference was considered statis-
tically signiﬁcant when P! 0.05.
Results
The histopathology was graded according to the Mankin
score, including structure, cells, tidemark integrity and
Safranin-O staining. Figure 1 shows the basic picture of
the Safranin-O stain reading in these specimens: normal,
slight reduction, moderate reduction, severe reduction and
no dye noted. The overall degenerative level in the knee
cartilage of these OA patients ranged from 4 to 13 on the
Mankin scale (Table I). The highest score (8.3) was found at
Site 6 and the lowest score (7.4) at Site 5. The average
Mankin score was 7.8 (range of 3e13). The differences
between the Mankin scores of the six sites were not
signiﬁcant. The frequency of occurrence of the 4977-bp
mtDNA deletion in OA group is also shown in Table I. The
amount of mtDNA deletion was denoted as ‘‘C’’ when the
proportion of 4977-bp-deleted mtDNA was higher than
0.012% (213) and denoted as ‘‘C/’’ when the mtDNA
deletion was detectable but not distinct (as shown in Fig. 2).
The correlations between the frequency of occurrence of
the 4977-bp mtDNA deletion and the Mankin score in the
OA patients were not statistically signiﬁcant.
The 4977-bp mtDNA deletion was detected in one or
more sites of the knee cartilage in 17 (94.4%) of the 18
patients with idiopathic OA. The differences in the frequen-
cies of occurrence of the 4977-bp mtDNA deletion at each
sampling area were borderline signiﬁcant (PZ 0.052)
(Table I). The frequency of occurrence of the mtDNA
deletion was highest at Site 1 (88.9% of the samples) and
lowest at Site 4 (41.2%). In the AC group, the 4977-bp
deletion was detected in 9 (95%) of the 10 patients; the
lowest mutation frequency of 10.0% was found at Site 4
(Table II). The frequencies of occurrence of the deletion at
each site in the AC group were not signiﬁcantly different.
The 4977-bp deletion was not detected in all specimens
collected from the nine young patients who had arthroscopic
surgery. The frequencies of occurrence of 4977-bp mtDNA
deletion in sampling specimens of OA group, AC group and
YC group were 65/107, 22/60, and 1/27, respectively.
Discussion
In humans, mtDNA mutations accumulate preferentially
in post-mitotic tissues that are active in oxidative metabo-
lism1,6,52; high levels of mtDNA with a deletion were found
in high-energy-demand tissues such as brain, cardiac
muscle and skeletal muscle4,5,7,14,17,24,27. Articular cartilage
chondrocytes must manage to survive and maintain tissue
integrity in an avascular, hypoxic milieu which requires
adaptively increased anaerobic glycolysis to support ATP
synthesis19,20,31,26,44,45. However, oxygen does diffuse intoarticular cartilage, and articular chondrocytes possess
mitochondria to perform aerobic metabolism in vitro11. It
was estimated that mitochondrial oxidative phosphorylation
may account for up to 25% of the ATP produced in articular
cartilage26.
In this study, we detected the 4977-bp deletion of mtDNA
in knee cartilage retrieved from elderly patients with
idiopathic OA and from AC. The frequency of occurrence
of the 4977-bp mtDNA deletion in the OA group (65 of 107
knee cartilage specimens) was signiﬁcantly higher than that
in AC group (22 of 60 specimens; PZ 0.004). The 4977-bp
deletion of mtDNA was found in only 1 of 27 specimens
from subjects in the young group; the frequency of
occurrence of this deletion was signiﬁcantly greater in the
AC group as compared to the young group (PZ 0.002).
Our ﬁndings indicate that the frequency of occurrence of
mtDNA mutation increases with age and that the 4977-bp
mtDNA deletion may be associated with the aging process
in knee cartilage. Since cartilage is a hypoxic tissue
compared with the other neuromuscular tissues, the density
of mitochondria in the chondrocytes of osteoarthrotic
cartilage is lower3,50,51. This may account for, at least
partly, our observation that the frequency of occurrence and
proportion of 4977-bp deletion of mtDNA in joint cartilage
are lower than those of the other oxidative tissues such as
brain and skeletal muscle. Even so, accumulation of mtDNA
molecules with point mutations and deletions in chondro-
cytes may impair mitochondrial function and induce the
degenerative process in the cartilage.
In the examination of the correlation between idiopathic
OA and mtDNA mutation, although the Mankin scores in
the OA patients were found moderately high (average of
7.9 out of 14), we did not ﬁnd a signiﬁcant correlation
between the presence of 4977-bp deletion of mtDNA and
OA severity. As an example, patient number 4 in the OA
group, who did not have the mtDNA deletion in any of the
knee specimens, scored an average of 7 on the Mankin
scale. Thus, mtDNA mutations are not always present in
the knee cartilage of elderly OA patients. It has been
reported that higher turn-over rate was found in osteo-
arthrotic cartilage compared with normal cartilage32.
Several previous studies demonstrated that smaller
mtDNA molecules repopulate the organelles faster6,8.
These previous observations are consistent with our
ﬁndings of this study. Those patients who received total
knee replacement surgery were cases with severe osteo-
arthrotic knees, the knee cartilages were almost ﬂattened.
So higher replication efﬁciency of smaller mtDNA with
a deletion may increase the proportion of mtDNA with
4977-bp deletion in early osteoarthrotic knee cartilage, but
in severe OA cartilage, the proportion of mtDNA with
4977-bp deletion may decrease due to loss of cartilage
tissues and higher turn-over rate of chondrocyte which
dispose of the cells harboring deleted mtDNA.
It has been demonstrated that degeneration in knee
cartilage may be induced by the multi-factorial aging
process15,18,46. The 4977-bp deletion of mtDNA may be
involved in the development of idiopathic OA in the knee
joint. The other possibility is that OA triggers an increase of
mtDNA deletions in knee cartilage.
The outer edge of the cartilage of the lateral tibial condyle
with meniscal coverage had the highest frequency of
mtDNA deletion in both the OA and AC groups. The
cartilage from the central part of the medial tibial condyle
without meniscal coverage had the lowest frequency of
mtDNA deletion. The higher-pressure areas of knee
cartilage are located on the uncovered part of the articular
1007Osteoarthritis and Cartilage Vol. 13, No. 11Fig. 1. An illustration of the application of the histologic-histochemical grading system to the osteoarthrotic knee cartilage of specimen no. 12-1
(54 y/o female), 15-1 (76 y/o man), 3-1 (78 o/y female), 13-1 (54 8/0 female), and 6-1 (72 y/o man). The photomicrographs A, B, C, D, E
indicate the cartilage specimens stained with HE (4X in A, B, C, E, 10X in D, left photograph) and with Safranin-Oefast greeneiron hemoxylin
(40X in A, B, C, D, 20X in E, right photograph). The Safranin-O-fast stain recording scores of A, B, C, D and E were normal (0), slight reduction
(1), moderate reduction (2), severe reduction (3) and no dye noted (4). They demonstrate the histological appearance and histochemical
appearance on which the grading was based.cartilage of the medial and lateral compartments9. The non-
contacted peripheral areas of both medial and lateral
compartments display the lowest contact pressure9. In our
patients, the 4977-bp mtDNA deletion occurred most
frequently in the lateral peripheral tibial cartilage, which
has the lowest contact pressure. Conversely, the 4977-bp
mtDNA deletion occurred least often in the central part of
the medial tibial condyle without meniscal coverage, which
has the highest contact pressure.
Part of our rationale for probing knee cartilage for the
presence of the 4977-bp mtDNA deletion was thepresumption that tissue with a lower turn-over rate would
accumulate deleted mtDNA with time. In contrast, tissues
with a higher turn-over rate could dispose of the cells
harboring deleted mtDNA. For example, the slow-growing
skin tissue harbors higher levels of mtDNA with the 4977-bp
deletion than does the faster growing tissue in cancerous
and precancerous skin tissues38. Similarly, muscle harbors
a signiﬁcantly higher proportion of deleted mtDNA than does
the testis24. In oral cancer tissue, the higher proportion of
deleted mtDNA was noted in peri-tumor tissue25. Higher turn-
over rate was found in osteoarthrotic cartilage compared
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Table I
The 4977-bp deletion in mtDNA and degenerative level with Mankin score at different sites of the knee cartilage of OA patients
Patient ID Sex Age (years) Site*
1 2 3 4 5 6
y Score Score Score Score Score Score
1 M 72 C/ 11  11 C 6 C 7  9  9
2 F 73 2X 10 2X 8 C 12 ND ND C 9 C 12
3 F 78 C 10 32X 10  11  9 C 7 C 12
4 M 79  8  4  7  9  6  8
5 F 72  6  6 C/ 4  10 C 9 C 5
6 M 72 C 3 4X 4 C 7 C 7  4 C/ 6
7 M 72 C 6  7 C 6  7 8X 6  5
8 F 67 C 8  8 C/ 5  6  5  6
9 F 67 8X 7 8X 5 C 8 2X 7 C/ 7  13
10 M 76 C 6  8  10  7 X 7  7
11 M 76 C 6 C 5 C 6 32X 6  7 C/ 6
12 F 54 C 5 4X 6 C 6 C/ 5 C/ 7 C 6
13 F 54 C 6 C/ 6  4  5 C/ 5  4
14 M 72 C 10 C 11 2X 10 16X 10 4X 10 8X 12
15 M 76 C 5 C 5  12  12  5 10
16 F 58 C 8  10  10  9 C 11  6
17 M 72 2X 12 8X 12 C 10  10  10 C 12
18 F 75 C 12 4X 12 C 8 C 9 C 10  11
Avg 70.3 88.9% 7.7 61.1% 7.7 66.7% 7.9 41.2% 7.9 61.1% 7.4 44.4% 8.3
P-value of detection rate in six sites of knee cartilage: 0.052
*Site 1: Outer edge of lateral condyle of tibia with meniscus coverage; Site 2: Central part of lateral tibial condyle without meniscus
coverage; Site 3: Medial edge of medial tibial condyle with meniscus coverage; Site 4: Central part of medial tibial condyle without meniscus
coverage; Site 5: Inferior-central part of lateral femoral condyle; Site 6: Inferior-central part of medial femoral condyle.
y: Undetectable by 35-cycle PCR;C/: Detectable but not distinct;C: Detectable with a proportion lower than 0.012% (213); XZ 213;
ND: Not done.
1009Osteoarthritis and Cartilage Vol. 13, No. 11Fig. 2. Gel chromatograms of the PCR products ampliﬁed from mtDNA with 4977-bp deletion (upper panel, 524-bp) and total mtDNA (lower
panel, 533-bp) in the semi-quantitative analysis of 4977-bp-deleted mtDNA. The PCR products of serially diluted DNA samples were
separated on 1.5% agarose gels followed by staining with 0.01% ethidium bromide. The two typical gel chromatograms revealed 0.012% of
4977-bp-deleted mtDNA (A) and detectable but not distinct level of 4977-bp deletion of mtDNA (B) in two bone tissue samples, respectively.
M, 100-bp size marker; P, positive control.with normal cartilage32, and cartilage osteoarthrotic change
occurs predominantly in the area with high mechanical
stimulation54, which inﬂuence the biosynthetic activity of
chondrocytes39,53, and therefore may play a role in the
adaptation and remodeling of articular cartilage. This
phenomenon may explain our ﬁnding of a higher incidence
of 4977-bp deletion of mtDNA in the peripheral cartilage ofthe joint. Contact pressure is lower in the peripheral
cartilage as compared to the central cartilage; the turn-over
rate may be greater in the central cartilage to cope with the
loading situation.
There are several limitations in this study. One problem
that potentially complicates an investigation of the cartilage
in OA is the enormous variability in the lesion. ThisTable II
The 4977-bp deletion in mtDNA at different sites in the knee cartilage of AC and YC
Patient ID Sex Age (years) Site*
1y 2 3 4 5 6
AC1 M 85   C   
AC2 F 63  C    
AC3 M 53 C C 4X  C 
AC4 M 79 X    C C
AC5 M 67 C C C   C
AC6 F 67  C  C  --
AC7 M 73  8X C  C C
AC8 F 54 C  2X   
AC9 M 52      
AC10 M 66 C     
Avg 65.9 5/10 5/10 5/10 1/10 3/10 3/10
PZ 0.332
YC1 M 27    X  
YC2 F 17      
YC3 M 23      
Avg 22.3 0 0 0 1/3 0 0
y: Undetectable by 35-cycle PCR; C/: Detectable but not distinct; C: Detectable with a proportion lower than 0.012%; detection rate:
XZ 213; ND: Not done.
*Site 1: outer edge of lateral condyle of tibia with meniscus coverage; Site 2: central part of lateral tibial condyle without meniscus coverage;
Site 3: medial edge of medial tibial condyle with meniscus coverage; Site 4: central part of medial tibial condyle without meniscus coverage;
Site 5: inferior-central part of lateral femoral condyle; Site 6: inferior-central part of medial femoral condyle.
1010 M.-C. Chang et al.: Mitochondrial DNA deletion in cartilageheterogeneity makes representative sampling of the tissues
very difﬁcult. We collected knee cartilage from patients who
had signiﬁcant degrees of OA. Indeed, some patients had
areas of bare bone usually situated on the weight-bearing
surface. The only cartilage obtainable from these knee
joints was that in the involved sites or the nearest area.
Secondly, whether factors such as age, height, weight,
duration of disease, level of activity, and concurrent
problems exert an effect remains unknown; these factors
may independently alter the incidence and proportion of
mtDNA mutations and the histologic appearance. In
a correlative study, this could be a source of error. Thirdly,
we used only the Mankin score to represent the OA
severity; use of a single criterion may not fully represent the
degree of cartilage degeneration. Other indicators include
roentgenographic changes, gross anatomic changes, his-
topathologic changes, and biochemical alterations may
provide better functional assessment of the cartilage.
Despite the above caveats, we found that the 4977-bp
deletion of mtDNA occurs in the knee cartilage of elderly
patients with idiopathic OA more frequently compared with
the non-OA aged patients. However, we were not able to
ﬁnd a correlation between the OA severity with the
incidence or the amount of 4977-bp deleted mtDNA. The
role of mtDNA deletion in the pathogenesis or progression
of idiopathic OA warrants further investigation.
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